Error in Author’s Name and Degree

• November 1, 2026

Can Immunopeptidomics Redefine Cancer Immunotherapy Development?

Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines

• by Katherine Tran

• November 3, 2026

• 4 min

Bruton Tyrosine Kinase Inhibitor–Associated Pericardial Events by Agent and Generation

• by Vinicius De Sousa Barzon Serra, Ramzi Ibrahim, Julia Zanco, Amjed Al Abdel, Amal Youssef, Dina Hauptschein, Karam Albdour, Luke Dreher, Hema Narayanasamy, Kwan Lee, Balaji Tamarappoo, J. Christopher Ray, Talal Hilal, Luis R. Scott, Joerg Herrmann, Chadi Ayoub, Reza Arsanjani

• November 9, 2026

Correction: Effectiveness of a Home-Based and Group-Based Tele-Exercise Program for Breast Cancer Survivors: Pilot Randomized Controlled Trial

• by Yang Gao, Yan Sun, Xueying Wang, Oi Kwan Chun, Brigitte Kim Yook Fung, Wai Wun Sara Fung

• November 11, 2026